LON:ABC Abcam (ABC) Share Price, News & Analysis → Millionaire-Making “Wealth Pattern” Just Repeated on April 22 (From Paradigm Press) (Ad) Free ABC Stock Alerts GBX 1,226 +123.00 (+11.15%) (As of 12/13/2022) Add Compare Share Share Today's Range 1,115▼ 1,25950-Day Range 1,226▼ 1,22652-Week Range 1,013.57▼ 1,760Volume6.37 million shsAverage Volume392,791 shsMarket Capitalization£2.81 billionP/E Ratio20,433.33Dividend Yield0.91%Price TargetN/A Stock AnalysisStock Analysis Get Abcam alerts: Email Address Ad Paradigm PressMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.This Crypto bull market is not even halfway over About Abcam Stock (LON:ABC)Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.Read More ABC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABC Stock News HeadlinesMay 29, 2024 | msn.comWho are the 120 business leaders backing Labour?May 29, 2024 | americanbankingnews.comAbcam (LON:ABC) Shares Cross Below 200 Day Moving Average of $1,226.00May 23, 2024 | msn.comAbcam agrees to be acquired by Danaher in $5.7B dealMay 22, 2024 | msn.comCambridge Wide Open Day set to showcase the UK’s awesome science and tech hubMay 15, 2024 | finance.yahoo.comGlobal $16.8 Bn Lateral Flow Assay Market Forecast, 2029: Rising Demand in the Food & Beverage Industry Presenting Lucrative OpportunitiesMay 14, 2024 | uk.news.yahoo.comThree week closure for busy Somerset roadMay 13, 2024 | uk.style.yahoo.comSurvey reveals how female small business owners measure successMay 13, 2024 | uk.finance.yahoo.comUnderstanding and Implementing Corporate Governance Frameworks: Building a Stronger Organisation Training CourseMay 9, 2024 | finance.yahoo.comLazard Welcomes Michele Colocci as Vice Chairman, Investment Banking and Managing Director, HealthcareMay 3, 2024 | finance.yahoo.comIn Vitro Diagnostic (IVD) Reagents Market worth $113.15 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.April 16, 2024 | msn.comResearchers discover cause of rare congenital lung malformationsApril 9, 2024 | finance.yahoo.comDNA Methylation Market Analysis 2024-2032 by Product, Technology, Application, End User, and Region - Industry to Rise at a 13.9% CAGRMarch 27, 2024 | finanznachrichten.deCell Culture Market Worth $57.9 billion | MarketsandMarketsMarch 25, 2024 | uk.finance.yahoo.comGlobal Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized MedicineMarch 18, 2024 | sg.finance.yahoo.comSuper Micro Computer, Deckers Outdoor make S&P 500 debutFebruary 25, 2024 | msn.comBill Gates' 16 Dividend Stocks To BuyFebruary 21, 2024 | uk.finance.yahoo.com3D Cell Cultures Market 2024-2028: Global Demand for 3D Cell Culture Solutions Surges with Expanding Biotechnology ApplicationsFebruary 19, 2024 | msn.comWhy science parks are importantFebruary 14, 2024 | finance.yahoo.comDanaher Corporation: Reaffirming BUY, raising target to $285February 5, 2024 | finanznachrichten.deRecombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets.February 5, 2024 | uk.finance.yahoo.comDanaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentFebruary 3, 2024 | seekingalpha.comDanaher: Better Positioned For The FutureFebruary 2, 2024 | finance.yahoo.comTop Stock Reports for Eli Lilly, Danaher & CitigroupFebruary 1, 2024 | finanznachrichten.deLazard Reports Fourth-Quarter and Full-Year 2023 ResultsJanuary 30, 2024 | finanznachrichten.deDanaher Corporation: Danaher Reports Fourth Quarter and Full Year 2023 ResultsSee More Headlines Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ABC CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000FaxN/AEmployees1,650Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio20,433.33 Forward P/E Ratio33.28 P/E Growth1.57Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio31.60 Current Ratio1.27 Quick Ratio0.89 Sales & Book Value Annual Sales£350.40 million Price / Sales8.02 Cash FlowGBX 50.93 per share Price / Cash Flow24.07 Book ValueGBX 318.30 per share Price / Book3.85Miscellaneous Outstanding Shares229,272,000Free FloatN/AMarket Cap£2.81 billion OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Alan Thomas Hirzel BS (Age 54)M.B.A., M.S., MBA, MS, CEO & Exec. Director Comp: $1.23MMr. Michael Shaun Baldock B.A. (Age 58)CFO & Director Comp: $881.14kMr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsMarc PerkinsGen. Counsel & Company Sec.Emma SceatsSr. VP of Sales, Service & Bus. Devel.Mr. Nick SkinnerSr. VP of HRMr. Mark BushfieldSr. VP of Research & InnovationMs. Kirstie Speck BBusScHead of Consumer InsightsMs. Yvonne ChienSr. VP of Customer ExperienceMore ExecutivesKey CompetitorsBTGLON:BTGGenusLON:GNSOxford Nanopore TechnologiesLON:ONTErgomedLON:ERGOPureTech HealthLON:PRTCView All Competitors ABC Stock Analysis - Frequently Asked Questions How have ABC shares performed in 2024? Abcam's stock was trading at GBX 1,226 at the beginning of 2024. Since then, ABC stock has increased by 0.0% and is now trading at GBX 1,226. View the best growth stocks for 2024 here. What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA). How do I buy shares of Abcam? Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:ABC) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abcam With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.